Alpha Tau Medical Ltd. (DRTS) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
DRTS currently has 88M outstanding shares. with minimal authorized share overhang for future dilution. The company has significantly diluted shareholders by 37.26% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Mar 09, 2026 |
20-F filing | 88.0M shares outstanding |
88M | 0 |
| Jun 23, 2025 |
F-3 filing: This F-3 filing outlines the potential offering and sale of up to 3,463,202 ordinary shares by selling shareholders, with the company not receiving any proceeds from these sales, but expecting approximately $12.26 million from the exercise of IR/PR Warrants. |
85M | 0 |
| Mar 12, 2025 |
20-F filing | 63.5M shares outstanding |
64M | 3.9M |
| Mar 07, 2024 |
20-F filing | 69.7M shares outstanding |
70M | 0 |
| Sep 11, 2023 |
F-3 filing: This F-3 filing relates to the resale by the selling shareholder of up to an aggregate of 1,100,000 ordinary shares. |
69M | 0 |
| Apr 03, 2023 |
POS AM filing: This prospectus relates to the issuance of ordinary shares upon exercise of warrants and resale of ordinary shares by selling securityholders. |
69M | 0 |
| Apr 03, 2023 |
F-3 filing: The company is offering ordinary shares, warrants, debt securities, subscription rights and units up to $200,000,000 in the aggregate. |
69M | 0 |
| Mar 09, 2023 |
20-F filing | 69.1M shares outstanding |
69M | 0 |
| Sep 06, 2022 |
POS AM filing: This POS AM filing relates to the issuance of ordinary shares upon exercise of warrants and resale of ordinary shares by selling securityholders. |
69M | 0 |
| Apr 15, 2022 |
F-1 filing: This is an F-1 filing related to the potential offering of ordinary shares through the exercise of warrants and sales by selling securityholders. |
68M | 0 |
| Mar 28, 2022 |
20-F filing | 40.4M shares outstanding |
40M | 0 |